Elkfork Partners’s Celgene Corp CELG Stock Holding History

Elkfork Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.78M	Buy	17,974 +8,558	+91%	+$813K	0.04%	289
2019 Q2	$870K	Sell	9,416 -189,090	-95%	-$18M	0.02%	432
2019 Q1	$18.7M	Sell	198,506 -225,412	-53%	-$19.7M	0.47%	54
2018 Q4	$27.2M	Sell	423,918 -129,118	-23%	-$9.53M	0.77%	28
2018 Q3	$49.5M	Sell	553,036 -43,494	-7%	-$3.84M	1.18%	15
2018 Q2	$47.4M	Sell	596,530 -18,018	-3%	-$1.5M	1.22%	16
2018 Q1	$54.8M	Buy	614,548 +4,246	+0.7%	+$408K	1.48%	12
2017 Q4	$63.7M	Sell	610,302 -44,902	-7%	-$5.07M	1.73%	10
2017 Q3	$95.5M	Sell	655,204 -19,778	-3%	-$2.69M	2.77%	4
2017 Q2	$87.7M	Sell	674,982 -20,768	-3%	-$2.54M	2.64%	4
2017 Q1	$86.6M	Sell	695,750 -1,760	-0.3%	-$211K	2.66%	4
2016 Q4	$80.7M	Buy	+697,510	New	+$77.7M	2.66%	5

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Elkfork Partners's CELG Position: Q3 2019 in Review

Elkfork Partners increased its Celgene Corp (CELG) stake by 91% in Q3 2019, buying an estimated $813K and bringing the position to 17,974 shares worth $1.78M. The position accounts for 0.04% of the portfolio, ranked #289.

Elkfork Partners first reported a position in CELG in Q4 2016 and has held it in 12 quarters since. The position peaked at $95.5M in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

Elkfork Partners held 17,974 shares of Celgene Corp worth $1.78M as of Q3 2019.
Elkfork Partners bought 8,558 Celgene Corp shares in Q3 2019, an estimated $813K.
Celgene Corp made up 0.04% of Elkfork Partners's portfolio in Q3 2019, its #289 holding.
Elkfork Partners first reported a position in Celgene Corp in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Celgene Corp position peaked at $95.5M in Q3 2017.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.